Injection Pen Market - Trends Forecast Till 2028

Injection Pen Market, by Product Type (Disposable, Reusable Pens), Therapy (Diabetes (Insulin, GLP-1), Growth Hormone, Osteoporosis, Fertility, Autoimmune disease, Cancer), End User (Hospitals, Clinics, Home Care) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: November, 2021

Base Year Estimate: 2020

Report ID: D-HC-IPM-373

Format:  

Number of Pages: 384

Domain: Healthcare

Injection Pen Market – Trends Forecast Till 2028

The global Injection Pen market size is projected to reach USD 53.4 billion by 2026 at a CAGR of 7.3% from USD 37.7 billion in 2021 during the forecast period 2021-2028.

Injection pen is an injectable device which is in the form of a pen. This device is used to deliver insulin (primarily) into the subcutaneous tissue of the body. This can be done by one on its own and thus reduce the dependency over doctors and others. The syringe is pushed by keeping it on the skin and is injected at an angle of 90 degree.

With the growing incidents of chronic cases along with the increased number of regulatory approvals required and the technological advancements in the sector are some of the factors that have supported long-term expansion for Injection Pen Market.

The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. But the injection pen market has not been significantly affected since the patients already using the pens continued with their usage although a supply chain crisis was observed along with marginal decline in trade during the lockdown.

Injection Pen Market Analysis

North America is expected to be the largest market during the forecast period. Due to higher prevalent cases of diabetes and the favourable reimburse scenario has led to growth in the commercial refrigeration equipment in the region.

Injection Pen Market is segmented into Product type, therapy, and end user and geography.

On the basis of Product Type

  • Disposable Injection Pens
  • Reusable Injection Pens

On the basis of End-User

  • Home-care Settings
  • Hospitals & Diagnostic Clinics

On the basis of Implementation

  • Diabetes
    • Insulin therapy
    • GLP-1 therapy
  • Growth Hormone
    • Osteoporosis
    • Fertility
    • Auto-immune Diseases
    • Cancer
    • Other Therapies

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Injection Pen Market Primary Respondents

 

Key Players

  • Novo Nordisk A/S, Becton
  • Dickinson and Company
  • Ypsomed Holding AG
  • Sanofi
  • Eli Lilly and Company
  • Merck KGaA, AstraZeneca plc
  • F. Hoffmann-La Roche Ltd
  • Owen Mumford, Sulzer Ltd.
  • Sun Pharmaceutical Industries Ltd
  • Pfizer, Biocon Ltd.
  • Lupin Ltd.
  • Wockhardt Ltd., AptarGroup, Inc.
  • Novartis AG
  • Gerresheimer AG
  • Bespak Europe Ltd.
  • SHL Medical AG
  • Boehringer Ingelhem
  • Nemera France SA
  • Companion Medical
  • Jiangsu Delfu Medical Devices Co., Ltd.

Recent Developments

  • In June 2019, Toujeo SoloStar Pens by Sanofi from France received approval in Europe for its use.
  • In April 2020, a new Dupixent prefilled pen by Sanofi (France) received FDA approval for use in asthma, atopic dermatitis, and chronic rhinosinusitis with nasal polyposis.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Injection Pen market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 37.7 billion

Growth Rate

CAGR of 7.3% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2028

Report Segmentation

Product type, therapy, end user and geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Novo Nordisk A/S, Becton, Dickinson and Company, Ypsomed Holding AG, Sanofi, Eli Lilly and Company, Merck KGaA, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Owen Mumford, Sulzer Ltd., Sun Pharmaceutical Industries Ltd., Pfizer, Biocon Ltd., Lupin Ltd., Wockhardt Ltd., AptarGroup, Inc., Novartis AG, Gerresheimer AG, Bespak Europe Ltd., SHL Medical AG, Boehringer Ingelhem, Nemera France SA, Companion Medical, and Jiangsu Delfu Medical Devices Co., Ltd.

Available Customization

In addition to the market data for Injection Pen Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.